National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

iodine I 131 monoclonal antibody 3F8
A radioimmunoconjugate consisting of 3F8, a murine anti-GD2 ganglioside monoclonal antibody labeled with iodine 131 (I-131), with radioimaging and radioimmunotherapeutic properties. Using monoclonal antibody 3F8 as a carrier for I-131 results in the targeted imaging and/or destruction of cells expressing GD2. GD2 is a ganglioside which is overexpressed in malignant melanoma, neuroblastoma, and small cell carcinoma of the lung. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:I 131 Monoclonal Antibody 3F8
I131-MOAB-3F8
iodine I 131 MOAB 3F8



Previous:iodine I 125 anti-EGFR-425 monoclonal antibody, iodine I 131, iodine I 131 chimeric monoclonal antibody G-250, iodine I 131 ethiodized oil, Iodine I 131 Lipiodol
Next:iodine I 131 monoclonal antibody 81C6, iodine I 131 monoclonal antibody 8H9, iodine I 131 monoclonal antibody BC8, iodine I 131 monoclonal antibody CC49-deltaCH2, iodine I 131 tositumomab

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov